A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMassachusetts General Hospital

About this trial

The purpose of this study is to explore the feasibility and acceptability of a nurse-led, coping, and supportive care intervention for patients with triple-negative breast cancer. The intervention aims to improve psychosocial outcomes in patients with triple-negative breast cancer (e.g., quality of life (QOL), anxiety, fear of cancer recurrence (FCR)).

Eligibility criteria

Qualifiers

Diagnosis of stage 1-3 triple-negative breast cancer

Age ≥ to 18 years

Between one and 12 months post curative therapy

Reporting distress at least 4/10 on a one-item screener

Disqualifiers

Patients with stage 4 cancer

Patients with impaired cognition or serious mental illness that would preclude participation in study procedures

Trial design

Treatments tested in this trial

  • RESTORE
  • Enhanced Usual Care

Treatment groups

75 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Massachusetts General Hospital

Lead sponsor

National Cancer Institute (NCI)

Collaborator